Latest News and Press Releases
Want to stay updated on the latest news?
-
RALEIGH, N.C., May 03, 2018 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and...
-
RALEIGH, N.C., April 30, 2018 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the launch of the Company’s...
-
RALEIGH, N.C., April 17, 2018 (GLOBE NEWSWIRE) -- Syneos HealthTM (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO and CCO (Contract Commercial...
-
RALEIGH, N.C. , March 27, 2018 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that the company is a founding...
-
RALEIGH, N.C., March 06, 2018 (GLOBE NEWSWIRE) -- Syneos HealthTM (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer...
-
Highlights Combined Company net new business awards of $622.9 million for the fourth quarter and $2.55 billion for the full year 2017 representing growth of 16.5% for the full year 2017. Combined...
-
RALEIGH, N.C., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, has announced the appointment of Lisa van Capelle...
-
RALEIGH, N.C., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Syneos Health Communications today released a report that provides pioneering perspectives into patients’ thought processes as they confront a future...
-
RALEIGH, N.C., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Syneos HealthTM (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its fourth quarter and year end 2017...
-
RALEIGH, N.C., Jan. 22, 2018 (GLOBE NEWSWIRE) -- Syneos Health™ (NASDAQ:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that two of its advertising...